Fortress Biotech (NASDAQ:FBIO) just reported results for the first quarter of 2024.
- Fortress Biotech reported earnings per share of -$1.03. This was above the analyst estimate for EPS of -$1.73.
- The company reported revenue of $13.03 million.
- This was 7.78% worse than the analyst estimate for revenue of $14.13 million.